Lady Era

Pharmaceutical profile and regulatory status

Lady Era contains sildenafil citrate as its active ingredient, identical to the molecule found in male erectile dysfunction medication. Despite its branding suggesting female-specific use, it remains unapproved for any indication in women by UK medicines regulator the MHRA

Lady Era is not licensed in the UK, is not stocked in UK pharmacies and is not an over-the-counter product. Under UK law, all sildenafil-containing medicines remain strictly prescription-only.

Pharmacological mechanism and interactions

Lady Era works by blocking the PDE5 enzyme, causing increased nitric oxide levels which leads to blood vessel relaxation. This mechanism aims to enhance genital blood flow. The drug reaches peak concentration in the bloodstream 30-60 minutes after swallowing.

Several potentially dangerous interactions require awareness:

• Avoid taking with nitrate medications (e.g. angina drugs) – may trigger life-threatening blood pressure drops
• High-risk combinations include alpha-blockers (prostate medications) and HIV protease inhibitors
• Moderate interactions involve grapefruit juice (delays drug breakdown) and alcohol

The liver processes sildenafil primarily through the CYP3A4 enzyme pathway, explaining many drug interactions. Approximately 80% is excreted in the faeces and 13% in the urine.

Clinical uses and population considerations

Sildenafil is not licensed in the UK for female sexual dysfunction. Some prescribers use it off-label for:

– Arousal difficulties – Sexual desire issues linked to SSRI antidepressants

Important safety restrictions apply. Lady Era is contraindicated during pregnancy due to potential fetal harm, with no safety data for breastfeeding. Under-18s should never use this medication.

Patients with cardiovascular history (heart attack, stroke, unstable angina) face particular danger. Those with liver impairment or severe kidney impairment need a lower starting dose under medical supervision.

Standard dosage recommendations

The typical Lady Era regimen involves:

Take one 100 mg tablet 1–4 hours before anticipated sexual activity on an empty stomach. High-fat meals significantly delay absorption. Do not exceed one dose every 24 hours, and never crush or chew tablets.

Dosage adjustments are critical for certain groups:

No studies support continuous daily dosing – only on-demand use applies. Always swallow the tablet whole with water. Storage must be below 25°C in original packaging.

Handling and storage protocols

Proper storage ensures Lady Era tablets remain effective. Keep them below 25°C in their original blister packs, avoiding humid environments like bathrooms. Shield them from direct sunlight and UV light to prevent chemical degradation.

During transport, maintain moderate temperatures to prevent heat damage. This medication follows an as-needed regimen, so missed dose protocols don’t apply. Overdoses present serious hazards: symptoms include dangerously low blood pressure, painful prolonged erections (priapism), cardiac arrhythmias, and severe headaches. If overdose occurs, seek immediate emergency medical assistance

Contraindications and high-risk groups

Lady Era poses life-threatening risks for specific populations. Absolute contraindications

• Concurrent nitrate medication use (common angina treatments)
• History of non-arteritic anterior ischaemic optic neuropathy (sudden vision loss)
• Severe cardiovascular, hepatic, or renal impairment

Heightened caution

• Uncontrolled hypotension (blood pressure below 90/60 mmHg)
• Bleeding disorders or anatomical abnormalities
• Retinitis pigmentosa or other retinal conditions

Ophthalmological complications

Adverse effects and rarity tiers

Sildenafil reactions follow distinct occurrence patterns:

Report suspected adverse reactions through the MHRA Yellow Card scheme. Persistent tinnitus or cardiovascular symptoms demand urgent clinical evaluation.

Comparing therapeutic alternatives

This overview compares other medicines used for female sexual dysfunction:

For hypoactive sexual desire disorder, centrally acting medicines such as flibanserin have better clinical evidence than blood-flow enhancers like Lady Era, and there is little female-specific research on PDE5 inhibitors. Psychological and behavioural therapies offer an approach without medication risks.